-

09:25:04 PM

TECH Stock News

TECH - Bio-Techne Corp

06/22/22 7:00 AM

Nasdaq : TECH

acquisition

BIO-TECHNE TO ACQUIRE NAMOCELL

Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire

RHEA-AI

neutral

05/26/22 7:00 AM

Nasdaq : TECH

Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species.

Bio-Techne Corporation (NASDAQ: TECH) today announced Advanced Cell Diagnostics (ACD), a brand of

RHEA-AI

neutral

05/25/22 7:00 AM

Nasdaq : TECH

GLOBAL STUDY DEMONSTRATES ICE3 AND MAURICE CAPILLARY ISOELECTRIC FOCUSING COMPARABILITY IN THE JOURNAL OF ELECTROPHERESIS

Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of a global study in the Journal of Electrophoresis: Global Intercompany Assessment of icIEF Platform Comparability for the Characterization of Therapeutic Proteins . This publication

RHEA-AI

neutral

05/19/22 7:00 AM

Nasdaq : TECH

conferences

BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE

Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Jefferies 2022 Healthcare Conference on Wednesday, June 8, 2022, at 9:30 a.m. EDT. A live webcast of the presentation can be

RHEA-AI

neutral

05/12/22 7:00 AM

Nasdaq : TECH

Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria® Bladder Cancer Test

Bio-Techne Corporation (NASDAQ: TECH) and Nonagen Bioscience today announced an agreement for R&D Systems, a Bio-Techne brand, to exclusively manufacture Nonagen Bioscience's Oncuria ® bladder cancer diagnostic panel using xMAP Luminex ®

RHEA-AI

very positive

05/10/22 7:00 AM

Nasdaq : TECH

conferences

BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS

Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, will have a major scientific presence at the annual American Urological Association Conference (AUA) taking place May 13-16 in New Orleans, LA. Exosome

RHEA-AI

neutral

05/04/22 6:30 AM

Nasdaq : TECH

earnings

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS

Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022.Third Quarter FY2022 HighlightsThird quarter organic revenue increased by 17% (19% reported) to $290.4 million and 18% (22% reported) in

RHEA-AI

neutral

05/04/22 6:30 AM

Nasdaq : TECH

dividends

BIO-TECHNE DECLARES DIVIDEND

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2022. The quarterly dividend will be payable May 27, 2022, to all common shareholders of record on

RHEA-AI

neutral

05/02/22 7:00 AM

Nasdaq : TECH

conferences

BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE

Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the BofA Securities 2022 Healthcare Conference on Wednesday, May 11, 2022, at 2:40 p.m. PST. A live webcast of the presentation

RHEA-AI

neutral

04/26/22 7:00 AM

Nasdaq : TECH

BIO-TECHNE INCLUDED ON THE FORBES BEST EMPLOYERS FOR DIVERSITY 2022 LIST

Bio-Techne Corporation (NASDAQ: TECH) today announced that it has been included on the Forbes list of Best Employers for Diversity 2022. This prestigious award is presented by Forbes and Statista Inc., the world-leading statistics portal and industry

RHEA-AI

positive

1 2 3 4 5 6 7 8 9 10 Next